CRESCENT BIOPHARMA INC
CBIONASDAQ🏆 #2376 by market capEarnings Nov 5US Equity
$16.69▼ $0.62 (−3.69%)
Market closed · at close1h—
24h▼ 3.7%
7d—
14d—
30d—
1y—
🏦Market Cap
$595M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
52.6x
Expensive
Otter Score
53
Weak
📊
Analyst Ratings
Price
$16.69
Total
13
Raised
1
Lowered
5
Avg PT
$29.00
H / L
$29 / $29
| Institution | Action | Rating | Date |
|---|---|---|---|
HC Wainwright & Co. | Downgraded | Buy → Neutral | 2026-06-01 |
TD Cowen | Downgraded | Buy → Hold | 2024-07-26 |
Jefferies | Upgraded | Hold → Buy | 2021-11-12 |
Roth Capital | Reiterated | Buy | 2020-12-08 |
H.C. Wainwright | Reiterated | Buy | 2020-03-02 |
Piper Sandler | Downgraded | Overweight → Neutral | 2019-08-05 |
SunTrust Robinson Humphrey | Downgraded | Buy → Hold | 2019-08-05 |
Piper Jaffray | Downgraded | Overweight → Neutral | 2019-08-05 |
PiperJaffray | Reiterated | Overweight | 2019-04-12 |
Stifel | Reiterated | Buy | 2018-03-07 |
Stifel Nicolaus | Reiterated | Buy | 2018-03-07 |
Cowen & Co. | Reiterated | Outperform | 2016-08-15 |
Barclays | Reiterated | Overweight | 2014-02-04 |
One row per institution, most recent rating